Skip to main content
. 2023 Aug 8;23:517. doi: 10.1186/s12879-023-08510-7

Fig. 3.

Fig. 3

Clinical course of the patient. Fever and white blood cells decreased after the initiation of anti-tuberculosis treatment. HDAC: high-dose cytarabine, WBC: white blood cell, Neut: neutrophil, BT: body temperature, LVFX: levofloxacin, CFPM: cefepime, TEIC: teicoplanin, INH: isoniazid, PZA: pyrazinamide, EB: ethambutol, RFP: rifampicin, AZM: azithromycin, AMK: amikacin, MFLX: moxifloxacin